Citation Impact
Citing Papers
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
2013
Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia
2011 Science
Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia
2016
During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation
2009
Skeletal Muscle Tissue Engineering: Methods to Form Skeletal Myotubes and Their Applications
2013
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
2014 Standout
Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
2012 Standout
Omics/systems biology and cancer cachexia
2016
Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist
2014
Protein Degradation by the Ubiquitin–Proteasome Pathway in Normal and Disease States
2006
Redox Mechanisms of Muscle Dysfunction in Inflammatory Disease
2005
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?
2016
Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
2012
Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer
2014
Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
2016
Visceral protein status and caloric intake in exercising versus nonexercising individuals with end-stage renal disease
1999 Standout
Chronic inflammatory states: their relationship to cancer prognosis and symptoms
2011
Brown and beige fat: development, function and therapeutic potential
2013 Standout
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
2011 Standout
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
2014 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia
2014
Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands
2011
Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia
2015
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
2019 Standout
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Cancer cachexia
2005
Understanding the mechanisms and treatment options in cancer cachexia
2012
Cancer-associated cachexia
2018 Standout
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism
2013
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
2018
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
2007 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
STAT3 in the systemic inflammation of cancer cachexia
2016
Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group
2013 Standout
Muscle wasting in disease: molecular mechanisms and promising therapies
2014
Regulation of muscle protein synthesis and the effects of catabolic states
2013
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
mRNA Expression Signatures of Human Skeletal Muscle Atrophy Identify a Natural Compound that Increases Muscle Mass
2011
Role of Activin A and Myostatin in Human Cancer Cachexia
2015
Sarcopenia
2019 Standout
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
Hallmarks of Cellular Senescence
2018 Standout
Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice
2011
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
What We Talk About When We Talk About Fat
2014 Standout
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
2016 Standout
A 3D bioprinting system to produce human-scale tissue constructs with structural integrity
2016 Standout
The aging myostatin null phenotype: reduced adiposity, cardiac hypertrophy, enhanced cardiac stress response, and sexual dimorphism
2012
Inhibition of Stat3 Activation Suppresses Caspase-3 and the Ubiquitin-Proteasome System, Leading to Preservation of Muscle Mass in Cancer Cachexia
2015
AKT/PKB Signaling: Navigating the Network
2017 Standout
The Hallmarks of Aging
2013 Standout
Protein breakdown in cancer cachexia
2015
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
2012
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
2019 Standout
Cachexia and Sarcopenia: Emerging Syndromes of Importance in Dogs and Cats
2011
The role of mTOR signaling in the regulation of protein synthesis and muscle mass during immobilization in mice
2015
Circulating Activin A predicts survival in cancer patients
2017
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
2016
Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer
2018
Emerging Roles for the Transforming Growth Factor-β Superfamily in Regulating Adiposity and Energy Expenditure
2010
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting
2011
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
The pathogenesis and treatment of cardiac atrophy in cancer cachexia
2015
Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients
2015
Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia
2016
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic–pituitary–adrenal axis
2011
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia
2013
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
2010
Signaling mechanism of tumor cell‐induced up‐regulation of E3 ubiquitin ligase UBR2
2013
Ribosome Biogenesis: Emerging Evidence for a Central Role in the Regulation of Skeletal Muscle Mass
2014 Standout
Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue
2015
Mechanisms regulating skeletal muscle growth and atrophy
2013
Emerging role of extracellular vesicles in mediating cancer cachexia
2018
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Works of H.Q. Han being referenced
Targeting the myostatin signaling pathway to treat muscle wasting diseases
2011
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
2010
Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential
2013
Regulation of Protein Catabolism by Muscle-Specific and Cytokine-Inducible Ubiquitin Ligase E3α-II during Cancer Cachexia
2004
Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance
2011
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
2011